Chargement en cours...
Pharmacokinetics of Posaconazole Prophylaxis of Patients with Acute Myeloid Leukemia
Antifungal prophylaxis is routinely given to patients with hematologic malignancies at high risk for invasive fungal infections (IFI), yet breakthrough IFI may still occur. Posaconazole emerged as an excellent alternative for fungal prophylaxis in high-risk patients. There is limited data about phar...
Enregistré dans:
| Publié dans: | J Infect Chemother |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5459324/ https://ncbi.nlm.nih.gov/pubmed/26141814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiac.2015.05.011 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|